Caterina Foti Selected Research

Caterina Foti Research Topics

Disease

46	Allergic Contact Dermatitis 04/2024 - 05/2002
44	Hypersensitivity (Allergy) 01/2024 - 04/2003
17	Contact Dermatitis (Eczema, Contact) 01/2024 - 11/2002
12	Dermatitis 02/2024 - 11/2005
12	Atopic Dermatitis (Atopic Eczema) 01/2024 - 03/2005
10	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2024 - 05/2015
8	Eczema 10/2022 - 06/2007
6	Urticaria (Hives) 01/2021 - 01/2012
5	Skin Diseases (Skin Disease) 04/2024 - 03/2010
5	Acne Vulgaris 01/2024 - 09/2015
5	Neoplasms (Cancer) 01/2024 - 11/2021
5	Melanoma (Melanoma, Malignant) 01/2024 - 01/2009
5	Chronic Urticaria 11/2023 - 06/2018
5	COVID-19 10/2023 - 07/2020
5	Infections 10/2023 - 01/2002
5	Exanthema (Rash) 03/2023 - 02/2013
4	Anaphylaxis (Anaphylactic Shock) 01/2023 - 01/2009
4	Angioedema 01/2022 - 01/2012
3	Erythema 01/2024 - 09/2015
3	Warts (Wart) 03/2023 - 03/2022
3	Pruritus (Itching) 01/2022 - 09/2013
3	Photoallergic Dermatitis (Photoallergy) 01/2022 - 06/2010
2	Delayed Hypersensitivity (Hypersensitivity, Type IV) 04/2024 - 06/2005
2	Mastocytosis 10/2023 - 12/2021
2	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 08/2022
2	Gout 01/2022 - 02/2013
2	Cheilitis 08/2020 - 07/2014
2	Drug Hypersensitivity Syndrome 07/2020 - 11/2012
2	Erythema Multiforme 11/2017 - 09/2008
2	Leg Ulcer 06/2016 - 07/2007
2	Ulcer 07/2007 - 06/2007
1	Adenocarcinoma 02/2024
1	Unconsciousness (Loss of Consciousness) 01/2024
1	Hypercholesterolemia 01/2024

Drug/Important Bio-Agent (IBA)

13	AllergensIBA 04/2024 - 01/2009
8	Omalizumab (Xolair)FDA Link 11/2023 - 06/2018
7	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022 - 03/2005
6	dupilumabIBA 01/2024 - 01/2020
6	Irritants (Vesicants)IBA 01/2024 - 05/2003
5	secukinumabIBA 05/2024 - 11/2020
5	NickelIBA 01/2024 - 06/2005
5	VaccinesIBA 10/2023 - 03/2022
5	Proteins (Proteins, Gene)FDA Link 08/2023 - 11/2012
4	BNT162 VaccineIBA 02/2023 - 07/2021
4	CosmeticsIBA 11/2022 - 10/2017
4	anti-IgE antibodiesIBA 01/2022 - 01/2019
4	Ointments (Pastes)IBA 12/2008 - 11/2005
3	EnzymesIBA 01/2024 - 01/2021
3	Excipients (Suspending Agents)IBA 01/2023 - 01/2016
3	EmollientsIBA 10/2022 - 05/2010
3	AcrylatesIBA 08/2020 - 04/2018
3	MethacrylatesIBA 04/2020 - 01/2018
2	apremilastIBA 02/2024 - 01/2021
2	upadacitinibIBA 01/2024 - 01/2024
2	1,2-pentanediolIBA 12/2023 - 05/2010
2	Messenger RNA (mRNA)IBA 10/2023 - 03/2022
2	2019-nCoV Vaccine mRNA-1273IBA 03/2023 - 02/2023
2	AntigensIBA 12/2022 - 09/2022
2	VitaminsIBA 11/2022 - 01/2021
2	InterleukinsIBA 08/2022 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2022 - 01/2020
2	Microbial Collagenase (Clostridiopeptidase A)FDA Link 02/2022 - 06/2007
2	Promazine (Promazine Hydrochloride)FDA Link 01/2022 - 09/2017
2	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 11/2018
2	SteroidsIBA 07/2021 - 01/2009
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2021 - 12/2017
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 11/2017
2	CytokinesIBA 01/2021 - 11/2017
2	PolyphenolsIBA 01/2021 - 11/2017
2	Histamine Antagonists (Antihistamines)IBA 01/2021 - 01/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2020 - 01/2019
2	acrylic acid (acrylate)IBA 04/2020 - 01/2018
2	3-dimethylaminopropylamineIBA 04/2020 - 04/2003
2	thienopyridineIBA 01/2020 - 01/2019
2	ThienopyridinesIBA 01/2020 - 01/2019
2	Clopidogrel (Plavix)FDA Link 01/2020 - 01/2019
2	isobornyl acrylateIBA 11/2018 - 01/2016
2	4-phenylenediamine (p-phenylenediamine)FDA Link 07/2018 - 12/2010
2	CyanoacrylatesIBA 04/2018 - 05/2003
2	2-methyl-4-isothiazolin-3-oneIBA 04/2018 - 05/2017
2	RetinoidsIBA 09/2017 - 09/2015
2	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2017 - 07/2009
2	Epoxy Resins FDA Link 01/2013 - 09/2010
2	Immunoglobulin E (IgE)IBA 11/2012 - 01/2002
2	Ketoprofen (Orudis)FDA LinkGeneric 03/2011 - 03/2011
2	Cod Liver OilIBA 12/2008 - 10/2007
2	Cyanamide (Calcium Carbimide)IBA 01/2008 - 05/2003
2	IntegrinsIBA 02/2007 - 01/2004
1	Pemetrexed (MTA)FDA Link 02/2024
1	pembrolizumabIBA 02/2024
1	Cisplatin (Platino)FDA LinkGeneric 02/2024
1	Antineoplastic Agents (Antineoplastics)IBA 02/2024
1	Acitretin FDA Link 02/2024
1	Surface-Active Agents (Surfactants)IBA 01/2024
1	sorbitan sesquioleateIBA 01/2024

Therapy/Procedure

20	Therapeutics 02/2024 - 11/2004
3	Tattooing 01/2024 - 12/2010
2	Immunotherapy 02/2024 - 01/2023
2	Aftercare (After-Treatment) 03/2023 - 01/2022
2	Biological Therapy 08/2022 - 12/2021